Detalles de la búsqueda
1.
Bis(Disulfide)-Bridged Somatostatin-14 Analogs and Their [111In]In-Radioligands: Synthesis and Preclinical Profile.
Int J Mol Sci;
25(3)2024 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38339198
2.
[212Pb]Pb-eSOMA-01: A Promising Radioligand for Targeted Alpha Therapy of Neuroendocrine Tumors.
Pharmaceuticals (Basel);
16(7)2023 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37513897
3.
Synthesis and radiolabelling of PSMA-targeted derivatives containing GYK/MVK cleavable linkers.
R Soc Open Sci;
10(3): 220950, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36908985
4.
In Vivo Efficacy Testing of Peptide Receptor Radionuclide Therapy Radiosensitization Using Olaparib.
Cancers (Basel);
15(3)2023 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36765883
5.
[111In]In-CP04 as a novel cholecystokinin-2 receptor ligand with theranostic potential in patients with progressive or metastatic medullary thyroid cancer: final results of a GRAN-T-MTC Phase I clinical trial.
Eur J Nucl Med Mol Imaging;
50(3): 892-907, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36334104
6.
Synthesis and Evaluation of Two Long-Acting SSTR2 Antagonists for Radionuclide Therapy of Neuroendocrine Tumors.
Pharmaceuticals (Basel);
15(9)2022 Sep 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36145375
7.
Safety of [177Lu]Lu-NeoB treatment: a preclinical study characterizing absorbed dose and acute, early, and late organ toxicity.
Eur J Nucl Med Mol Imaging;
49(13): 4440-4451, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35951084
8.
Preclinical Assessment of the Combination of PSMA-Targeting Radionuclide Therapy with PARP Inhibitors for Prostate Cancer Treatment.
Int J Mol Sci;
23(14)2022 Jul 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35887398
9.
In vitro dose effect relationships of actinium-225- and lutetium-177-labeled PSMA-I&T.
Eur J Nucl Med Mol Imaging;
49(11): 3627-3638, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35556158
10.
Correction to: In vitro dose effect relationships of actinium225 and lutetium177labeled PSMAI&T.
Eur J Nucl Med Mol Imaging;
49(11): 3956-3957, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35614268
11.
Improved Multimodal Tumor Necrosis Imaging with IRDye800CW-DOTA Conjugated to an Albumin-Binding Domain.
Cancers (Basel);
14(4)2022 Feb 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35205609
12.
The Effect of VPA Treatment on Radiolabeled DOTATATE Uptake: Differences Observed In Vitro and In Vivo.
Pharmaceutics;
14(1)2022 Jan 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35057069
13.
Towards Complete Tumor Resection: Novel Dual-Modality Probes for Improved Image-Guided Surgery of GRPR-Expressing Prostate Cancer.
Pharmaceutics;
14(1)2022 Jan 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35057090
14.
Dosimetric Evaluation of the Effect of Receptor Heterogeneity on the Therapeutic Efficacy of Peptide Receptor Radionuclide Therapy: Correlation with DNA Damage Induction and In Vivo Survival.
J Nucl Med;
63(1): 100-107, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33837068
15.
Comparing the Effect of Multiple Histone Deacetylase Inhibitors on SSTR2 Expression and [111In]In-DOTATATE Uptake in NET Cells.
Cancers (Basel);
13(19)2021 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34638389
16.
Overcoming nephrotoxicity in peptide receptor radionuclide therapy using [177Lu]Lu-DOTA-TATE for the treatment of neuroendocrine tumours.
Nucl Med Biol;
102-103: 1-11, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34242948
17.
Necrosis binding of Ac-Lys0(IRDye800CW)-Tyr3-octreotate: a consequence from cyanine-labeling of small molecules.
EJNMMI Res;
11(1): 47, 2021 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33970376
18.
Correction to: Evaluation of Ac-Lys0(IRDye800CW)Tyr3-octreotate as a novel tracer for SSTR2-targeted molecular fluorescence guided surgery in meningioma.
J Neurooncol;
153(2): 223, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34014425
19.
Cancer-Associated Fibroblasts as Players in Cancer Development and Progression and Their Role in Targeted Radionuclide Imaging and Therapy.
Cancers (Basel);
13(5)2021 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33806468
20.
GRPr Antagonist 68Ga-SB3 PET/CT Imaging of Primary Prostate Cancer in Therapy-Naïve Patients.
J Nucl Med;
62(11): 1517-1523, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33789933